Research, analysis, and perspectives on enterprise AI, computational biotech, and the future of on-premise intelligence.
★ Featured
Security. Intelligence. Biology. Three pillars define our 2026 vision — watch the story unfold through immersive video and visual storytelling.
NovaGenAI builds custom AI models that convert biological datasets into machine-readable formats for drug discovery.
Regulated industries can't send data to the cloud. On-premise AI powered by NVIDIA DGX is the infrastructure shift.
From chatbots to fully autonomous systems — what AI agents are, how they work, and why enterprises deploy them.
Everything about NVIDIA's desktop AI supercomputer — specs, use cases, and why it changes on-premise AI.
The definitive comparison of AI deployment models. Cost, security, latency, compliance — broken down.
How NovaGenAI builds custom models on proprietary biological data, inspired by Google's research.
Google's research converts single-cell RNA data into natural language. What it means for biotech AI.
From drug discovery to protein folding — computational modelling cuts years off research timelines.
The evolution from single-omics to multi-omics AI and why integrating data types unlocks better predictions.
AI is compressing drug discovery timelines from a decade to months. How computational approaches reshape pharma.
Enterprise voice AI handles complex conversations, integrates with business systems, and operates in regulated environments.
90% of enterprise data is unstructured. AI document intelligence extracts, classifies, and acts on it.
Off-the-shelf models aren't enough. How enterprises build custom LLMs on their own data.
Complete guide to NVIDIA's AI software ecosystem — what each tool does and why enterprises need the full stack.